England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots
People under 30 have been told there may be a “small delay” to when they will receive a coronavirus vaccine, given adults in that age group are now being recommended to take an alternative jab to the one produced by AstraZeneca.
Jonathan Van-Tam, England’s deputy chief medical officer, said the rollout change was a “course correction” and a precaution against the “vanishingly rare” side-effect of blood clots.
